nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—MAOA—attention deficit hyperactivity disorder	0.812	1	CbGaD
Phenylephrine—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.0122	0.344	CbGeAlD
Phenylephrine—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00265	0.0749	CbGeAlD
Phenylephrine—Norepinephrine—ADRA2C—attention deficit hyperactivity disorder	0.00162	0.271	CrCbGaD
Phenylephrine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00152	0.043	CbGeAlD
Phenylephrine—MAOA—forebrain—attention deficit hyperactivity disorder	0.00151	0.0426	CbGeAlD
Phenylephrine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.00147	0.0416	CbGeAlD
Phenylephrine—Epinephrine—ADRA2C—attention deficit hyperactivity disorder	0.00147	0.246	CrCbGaD
Phenylephrine—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.00144	0.0406	CbGeAlD
Phenylephrine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.00141	0.04	CbGeAlD
Phenylephrine—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.00138	0.0391	CbGeAlD
Phenylephrine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.00129	0.0364	CbGeAlD
Phenylephrine—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.00127	0.036	CbGeAlD
Phenylephrine—ADRA1B—brain—attention deficit hyperactivity disorder	0.00112	0.0318	CbGeAlD
Phenylephrine—ADRA1D—brain—attention deficit hyperactivity disorder	0.0011	0.0311	CbGeAlD
Phenylephrine—Tapentadol—SLC6A4—attention deficit hyperactivity disorder	0.00104	0.174	CrCbGaD
Phenylephrine—MAOA—midbrain—attention deficit hyperactivity disorder	0.000995	0.0281	CbGeAlD
Phenylephrine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000825	0.0233	CbGeAlD
Phenylephrine—MAOA—nervous system—attention deficit hyperactivity disorder	0.000818	0.0231	CbGeAlD
Phenylephrine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000795	0.0225	CbGeAlD
Phenylephrine—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000788	0.0223	CbGeAlD
Phenylephrine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000777	0.022	CbGeAlD
Phenylephrine—MAOA—cerebellum—attention deficit hyperactivity disorder	0.00077	0.0218	CbGeAlD
Phenylephrine—Norepinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000689	0.116	CrCbGaD
Phenylephrine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000631	0.0178	CbGeAlD
Phenylephrine—Epinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000626	0.105	CrCbGaD
Phenylephrine—MAOA—brain—attention deficit hyperactivity disorder	0.000625	0.0177	CbGeAlD
Phenylephrine—Norepinephrine—DRD2—attention deficit hyperactivity disorder	0.000523	0.0878	CrCbGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000325	0.00221	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000321	0.00218	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000317	0.00215	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000317	0.00215	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000314	0.00213	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000311	0.00211	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000304	0.00207	CbGpPWpGaD
Phenylephrine—ADRA1B—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.000304	0.00207	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000302	0.00205	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000292	0.00198	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000279	0.0019	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.00188	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00027	0.00184	CbGpPWpGaD
Phenylephrine—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00027	0.00184	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000268	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000266	0.00181	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000261	0.00177	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00026	0.00176	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000254	0.00173	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000249	0.00169	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000244	0.00166	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000239	0.00163	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000236	0.00161	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000232	0.00157	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000231	0.00157	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00023	0.00156	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000222	0.00151	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000222	0.00151	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000218	0.00148	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000214	0.00145	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000211	0.00143	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000206	0.0014	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000206	0.0014	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000203	0.00138	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0002	0.00136	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000199	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000199	0.00135	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000197	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.00134	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000194	0.00132	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000194	0.00132	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00019	0.00129	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000187	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000187	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000184	0.00125	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000181	0.00123	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000181	0.00123	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00018	0.00122	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000177	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000177	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000176	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000171	0.00116	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000171	0.00116	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000171	0.00116	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.00114	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000166	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000166	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000166	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000164	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000164	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000163	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000161	0.0011	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000161	0.00109	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000158	0.00107	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000155	0.00105	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000155	0.00105	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000153	0.00104	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000152	0.00103	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000152	0.00103	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000151	0.00102	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00015	0.00102	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000147	0.001	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000147	0.000998	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000147	0.000996	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000985	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000145	0.000985	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000143	0.000973	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000142	0.000967	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00014	0.000954	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00014	0.000951	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00014	0.00095	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000138	0.000938	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000138	0.000938	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000138	0.000936	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000138	0.000935	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000136	0.000924	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000135	0.000919	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000135	0.000916	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000133	0.000906	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00013	0.000887	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00013	0.000887	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000129	0.000874	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000128	0.000872	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000127	0.000861	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000127	0.000861	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000126	0.000859	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000125	0.000852	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000124	0.000844	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000123	0.000834	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000123	0.000834	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000122	0.000831	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000122	0.000827	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000121	0.000821	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00012	0.000818	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000118	0.000802	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000115	0.000778	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000114	0.000776	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000112	0.000763	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000112	0.00076	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00011	0.00075	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000109	0.000738	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000108	0.000736	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000108	0.000734	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000107	0.000726	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000106	0.000724	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000105	0.000715	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000105	0.000715	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000104	0.000707	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000103	0.000699	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000102	0.000692	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.000691	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000101	0.000685	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000101	0.000685	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	9.96e-05	0.000677	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	9.93e-05	0.000675	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.79e-05	0.000666	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	9.62e-05	0.000654	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.45e-05	0.000643	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	9.37e-05	0.000637	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.34e-05	0.000635	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.34e-05	0.000635	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.24e-05	0.000628	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.16e-05	0.000623	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.07e-05	0.000617	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.05e-05	0.000615	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.01e-05	0.000612	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.7e-05	0.000591	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.61e-05	0.000586	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	8.51e-05	0.000578	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.26e-05	0.000562	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	8.19e-05	0.000557	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.18e-05	0.000556	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.14e-05	0.000553	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	8.13e-05	0.000552	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	8.07e-05	0.000549	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8e-05	0.000544	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.78e-05	0.000529	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.61e-05	0.000518	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	7.44e-05	0.000505	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.4e-05	0.000503	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.37e-05	0.000501	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.25e-05	0.000493	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.25e-05	0.000493	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.16e-05	0.000487	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.15e-05	0.000486	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.11e-05	0.000483	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.06e-05	0.00048	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.91e-05	0.00047	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.91e-05	0.00047	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.86e-05	0.000466	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.8e-05	0.000462	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.7e-05	0.000455	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.67e-05	0.000453	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.58e-05	0.000447	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.5e-05	0.000442	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.35e-05	0.000432	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.32e-05	0.00043	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.27e-05	0.000426	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	6.26e-05	0.000426	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.26e-05	0.000426	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.17e-05	0.00042	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	6.16e-05	0.000419	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.14e-05	0.000418	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.12e-05	0.000416	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.09e-05	0.000414	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.06e-05	0.000412	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.04e-05	0.00041	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.02e-05	0.000409	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.02e-05	0.000409	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.94e-05	0.000404	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.9e-05	0.000401	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.74e-05	0.00039	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.73e-05	0.000389	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.61e-05	0.000382	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.56e-05	0.000378	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.53e-05	0.000376	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.48e-05	0.000373	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.46e-05	0.000371	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.46e-05	0.000371	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.44e-05	0.000369	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.4e-05	0.000367	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.35e-05	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.34e-05	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.28e-05	0.000359	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.24e-05	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.1e-05	0.000346	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.03e-05	0.000342	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.03e-05	0.000342	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.01e-05	0.00034	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.94e-05	0.000336	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.92e-05	0.000334	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.85e-05	0.00033	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.79e-05	0.000326	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.77e-05	0.000324	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.67e-05	0.000317	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.46e-05	0.000303	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.39e-05	0.000299	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.24e-05	0.000288	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.17e-05	0.000284	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.08e-05	0.000278	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.96e-05	0.000269	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.89e-05	0.000264	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.88e-05	0.000263	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.84e-05	0.000261	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	3.8e-05	0.000258	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.71e-05	0.000252	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.65e-05	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.58e-05	0.000243	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.52e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.44e-05	0.000234	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.39e-05	0.00023	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.35e-05	0.000228	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.28e-05	0.000223	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.24e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.23e-05	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.19e-05	0.000217	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.13e-05	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.01e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.97e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.92e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.87e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.83e-05	0.000192	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.64e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.51e-05	0.00017	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	2.31e-05	0.000157	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.31e-05	0.000157	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	2.27e-05	0.000154	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.11e-05	0.000144	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.08e-05	0.000141	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.85e-05	0.000126	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.85e-05	0.000126	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.00012	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	1.63e-05	0.000111	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.4e-05	9.51e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.39e-05	9.45e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.35e-05	9.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.33e-05	9.02e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.1e-05	7.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.79e-06	6.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	6e-06	4.08e-05	CbGpPWpGaD
